FDI in pharma: the state of play
The pharmaceutical industry suffered a dip in FDI in 2020 as the Covid-19 pandemic hit, but did any countries manage…
By
Europe Understanding the Attractiveness for Investments
Latest in
Europe Understanding the Attractiveness for Investments
Alopecia areata steals the spotlight in time for possible treatment paradigm shift
With alopecia areata in the headlines, Clinical Trials Arena looks at a potential shake-up in its drug options and an…
By
Milltrust Ventures to invest in health tech platform Oncoshot
Oncoshot enables data-driven cancer trials and expedites enrolment in ones that are actively recruiting participants.
Velocity makes three tech invests to boost clinical trial engagement
In one investment, Velocity acquires TrierHealth, a secure platform that permits digital clinical trial execution.
Revealed: top clinical trial operations investment themes in 2022
Ethics had the strongest momentum when it came to clinical trial operations industry hiring patterns, climbing 48 places to rank…
By
Bharat prepares interim Phase I data for intranasal Covid-19 vaccine; reveal planned this month, investigator says
Bharat Biotech is reviewing interim safety and immunogenicity data from a Phase I trial investigating its intranasal Covid-19 vaccine BBV154,…
By
Oxford-AstraZeneca paediatric vaccine trial halted amid blood clot concerns
A trial of the Oxford-AstraZeneca Covid-19 vaccine in children and teens has been put on hold while the UK’s drug…
By
Oncopeptides’ Pepaxto divides investigators on superiority potential in Phase III myeloma trial; FDA approvable noninferiority would handicap uptake
Oncopeptides’ Pepaxto (melflufen flufenamide) has investigators split about whether it is able to demonstrate superior efficacy over Bristol-Myers Squibb’s (BMS’)…
By